Live Breaking News & Updates on Gates Ventures

Stay updated with breaking news from Gates ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UK-wide trials to begin on blood tests for diagnosing dementia

4.04.2024 - Cambridge researchers are helping lead countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK s shocking diagnosis rate. This is a ground-breaking study, to discover the best blood tests for dementia, not just Alzheimer s but any type of dementia and for anyone, whatever their background age and other health problems. ....

United Kingdom , James Rowe , Fiona Carragher , Jonathan Schott , Ashvini Keshavan , Ivan Koychev , Vanessa Raymont , Alzheimer Research United Kingdom , Department Of Clinical Neurosciences At Cambridge , National Institute For Health , Research At Alzheimer United Kingdom , Alzheimer Society , Care Research , James Rowe Professor , Clinical Neurosciences , Dementias Platform United Kingdom , Blood Biomarker Challenge , Research United Kingdom , National Institute , Gates Ventures , Professor James Rowe , Drs Vanessa Raymont , Dementias Platform United , Platform United Kingdom , Professor Jonathan Schott , Sheona Scales ,

Promising pathways to simplified Alzheimer's

<p>The Global Alzheimer&rsquo;s Platform Foundation<em><sup>&reg;</sup></em>, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over 1000 community-based participants from throughout the US compared the results of blood and digital biomarkers with brain amyloid PET scans or cerebrospinal fluid assays. The study<em> </em>revealed a strong correlation between several blood tests, particularly p-tau 217, with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer&rsquo;s disease (AD). This relationship was demonstrated across the entire study population including the 24% percent of Bio-Hermes participants from African American, Latino and other traditionally underrepresented communities, an unprecedented level of diversity. These findings will enhance the field&rsquo;s ability to provide a more economical, timely, and accurate diagnosis of Alzheimer&rsquo;s disease and s ....

District Of Columbia , United States , Jennifer Gaudioso , Dianar Kerwin , Lynn Hughes , Jason Bork , Tamiko Magee Rodgers , Cyndyb Cordell , Douglas Beauregard , John Dwyer , Eli Lilly , Richardc Mohs , Richard Mohs , Bio Hermes Collaborative Group , Global Alzheimer Platform Foundation , Journal Of The Alzheimer Association , Linus Health , Alzheimer Drug Discovery Foundation , University Of Gothenburg , Global Alzheimer , African American , African Americans , White Americans , Mild Cognitive Impairment , Bio Hermes Collaborative , Drug Discovery Foundation ,